Literature DB >> 3569705

Maternal and developmental toxicity of chronic aluminum exposure in mice.

M S Golub, M E Gershwin, J M Donald, S Negri, C L Keen.   

Abstract

The present study demonstrated aluminum-induced neurotoxicity in mouse dams and developmental retardation in their offspring following oral exposure to several dose levels during gestation and lactation. Female mice fed aluminum lactate (AL) at levels of 500 or 1000 ppm in their diet from Day 0 gestation to Day 21 postpartum were compared to mice which received a 100 ppm aluminum diet either ad libitum or pair-fed to the 1000 ppm AL group. Dams receiving the 500 and 1000 ppm AL diets showed signs of neurotoxicity beginning at Days 12-15 postpartum and showed significant weight loss. Offspring showed dose-dependent decreases in body weight (F = 6.47, p less than 0.001), crown-rump length (F = 7.37, p less than 0.0001), and ponderal index (F = 6.90, p less than 0.0002), at birth and preweaning. Absolute and relative liver and spleen weights were lower in pups from the high AL groups compared to controls (F = 3.34, p less than 0.025 and F = 15.54, p less than 0.001, respectively). Neurobehavioral development was somewhat delayed in aluminum-treated pups, but not in their pair-fed controls (F = 5.52, p less than 0.005). In addition to showing oral toxicity of excess AL during development dose-dependent toxic effects of parenteral aluminum exposure were demonstrated in pregnant mice which were injected subcutaneously with aluminum lactate solution at 10, 20, or 40 mg Al/kg body wt on Days 3, 5, 7, 9, 12, 13, and 15 of gestation. Maternal spleen and liver weights were significantly increased in aluminum treated animals (p less than 0.001 and p less than 0.05, respectively). Fetal crown-rump lengths were significantly reduced in the 20 mg/kg aluminum group (F = 9.79, p less than 0.001).

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3569705     DOI: 10.1016/0272-0590(87)90084-4

Source DB:  PubMed          Journal:  Fundam Appl Toxicol        ISSN: 0272-0590


  7 in total

1.  A study of the distribution of aluminium in human placental tissues based on alkaline solubilization with determination by electrothermal atomic absorption spectrometry.

Authors:  Pamela C Kruger; Lawrence M Schell; Alice D Stark; Patrick J Parsons
Journal:  Metallomics       Date:  2010-08-17       Impact factor: 4.526

Review 2.  Human health risk assessment for aluminium, aluminium oxide, and aluminium hydroxide.

Authors:  Daniel Krewski; Robert A Yokel; Evert Nieboer; David Borchelt; Joshua Cohen; Jean Harry; Sam Kacew; Joan Lindsay; Amal M Mahfouz; Virginie Rondeau
Journal:  J Toxicol Environ Health B Crit Rev       Date:  2007       Impact factor: 6.393

3.  Assessing the health risks of aluminum.

Authors:  J Orme; E V Ohanian
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

Review 4.  Aluminium in over-the-counter drugs: risks outweigh benefits?

Authors:  Claudia M Reinke; Jörg Breitkreutz; Hans Leuenberger
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606

5.  Aluminium sulphate exposure increases oxidative stress and suppresses brain development in Ross broiler chicks.

Authors:  Emin Oğuzhan Oğuz; Yaşar Enli; Barbaros Şahin; Cafer Gönen; Günfer Turgut
Journal:  Med Sci Monit       Date:  2012-03

Review 6.  Aluminum-induced entropy in biological systems: implications for neurological disease.

Authors:  Christopher A Shaw; Stephanie Seneff; Stephen D Kette; Lucija Tomljenovic; John W Oller; Robert M Davidson
Journal:  J Toxicol       Date:  2014-10-02

7.  Tamarindus indica ameliorates behavioral and cytoarchitectural changes in the cerebellar cortex following prenatal aluminum chloride exposure in Wistar rats.

Authors:  Ibe Michael Usman; Samuel Sunday Adebisi; Sunday Abraham Musa; Ibrahim Abdullahi Iliya; Victor Bassey Archibong; Ann Monima Lemuel; Keneth Iceland Kasozi
Journal:  Anat Cell Biol       Date:  2022-08-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.